Cell targeting for CF gene therapy: Identification of a new specific cell ligand and selection of infectious papillomavirus mutants  by Carpentier, A. et al.
4. New Therapies S31
119 Cell targeting for CF gene therapy: Identiﬁcation of a new speciﬁc
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Papillomavirus VLPs have the potential to deliver genes into numerous cell lines.
However, HPV pseudovirions do not or transduce poorly human airway epithelial
cells. The aim of this study was to redirect the tropism of HPV VLP vectors to
human airway cells. In a preliminary study, three peptides, described as airway cell
ligands, were inserted into the L1 major capsid protein of HPV-16. Cell internal-
ization of these chimeric VLPs compared to wild-type VLPs into 16HBe14O- cells
was increased, being dependent on the peptide use and the position of the insertion
within L1. However, no gene transfer with the corresponding pseudovirions was
detected in airway cells. To increase gene transfer, the minor capsid protein L2 was
inserted within the chimeric VLPs. However still no gene transfer was detected in
airway cells. This lack of gene transfer could be due either to lack of trafﬁcking by
an infectious pathway in airway cells or to the low level of infectious pseudovirions
generated.
To overcome these difﬁculties, we searched for other ligands using a phage display
system. A new peptide, LSPIRMR, that binds speciﬁcally to IB3−1 and S9 cells
was identiﬁed. In addition, to improved the understanding of the entry pathway
of VLPs into cells, the airway epithelial cell responses to transduction with HPV
pseudovirions is currently being investigated by suppression subtractive hybridiza-
tion (SSH). As there is a possibility that HPV pseudovirions are non-infectious
in airway epithelial cells, we are also producing auto-replicative pseudovirions to
select chimeric particles that infect airway cells. As a ﬁrst step, we have obtained
autoreplicative pseudovirions in 293 FT cells.
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Background: Non-viral pulmonary gene transfer for the treatment of acquired
or hereditary lung diseases including cystic ﬁbrosis, requires the development of
safe and highly efﬁcient synthetic vectors. Recently we discovered a novel class of
synthetic gene delivery systems, triblock and tetrafunctionnalized block copolymers,
that promoted high gene expression in the lung. Moreover we demonstrated that
partial galactosylation of these block copolymers dramatically increased their gene
expression efﬁciency in the lung.
Aim: To further improve the airway epithelial cells targeting through galactose
receptor recognition, we decided to synthesize full-galactosylated block copolymers
using “click” chemistry. The synthetic pathway relies on the copper-catalysed
Huisgen 1,3-dipolar cycloaddition between azide-terminated polymers and the
galactose moiety that contains an alkyne group.
Results: The azide-terminated block copolymers were obtained quantitatively in
a two steps procedure involving tosylation of hydroxyl groups and nucleophilic
substitution with sodium azide. The alkyne containing galactose was synthesized
from peracetylated galactopyranoside by reaction with butynol followed by sodium
methoxide mediated deprotection. The optimized “click” reaction was performed
in aqueous media at 55ºC for 2 days in the presence of a copper catalyst and led to
a quantitative galactose functionalization of the extremities of block copolymers.
Conclusion The “click” chemistry strategy allowed the quantitative functionaliza-
tion of triblock and tetrafunctionnalized block copolymers. These full-galactosylated
block copolymers may improve transgene expression in the lung in terms of
efﬁciency and safety compared to existing non-viral vectors.
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Background: Amphiphilic block copolymers have recently been developed and
displayed very efﬁcient in vivo transfection activity in various tissues. However
their mechanism remains unknown and better understanding of this mechanism
represents a major goal for the development of this new class of vectors.
Methods: We observed that lutrol, an amphiphilic block copolymer does not allow
to transfect in vitro cells, suggesting that environment (in vitro or in vivo) is strongly
involved in their mechanism. However electron microscopic examination of cells
transfected with DNA formulated with Lutrol indicated that DNA molecules were
internalized. The present study aimed at understanding this discrepancy between in
vitro and in vivo transfection behaviour of block copolymers.
Results: We observed that cell incubation with amphiphilic block copolymers
prior to cationic lipid mediated transfection improves the reporter gene expression.
Among the various steps going from cell internalization to transcription that
could be improved by the block copolymer we found that the DNA molecules
internalization step is probably the most important barrier on which the block
copolymer played.
Conclusion: Our results support that amphiphilic block copolymers improve trans-
fection efﬁciency by allowing a better crossing of the cell membrane barrier both
in vitro or in vivo. However even if the mode of entry of DNA in the presence of
block copolymer in cells is probably the same, the transfection efﬁciency is very
different. It is generally accepted that cells cultured in vitro mostly internalize DNA
by endocytosis requiring cationic lipid to escape the endosomes. DNA molecules do
not probably follow this pathway of internalization in vivo and thus do not required
cationic lipids.
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To develop novel bio-inspired non-viral vectors for lung gene therapy of cystic
ﬁbrosis, we synthesized a series of cationic lipids with a neamine headgroup
which incorporates rings I and II of the natural antibiotic aminoglycoside neomycin
B. Indeed, we reasoned that neamine might constitute a straightforward and
versatile building block for synthesizing a variety of lipophilic aminoglycosides
and modulating their characteristics such as size, topology, lipophilicity, number
of charges and charge density. Neamine derivatives bearing long dialkyl chains,
one or two neamine headgroups and ﬁve to ten protonatable amine functions were
prepared through the selective alkylation of the 4′- or the 5-hydroxyl function in
ring I and ring II of neamine, respectively. The transfection activity of the twelve
derivatives synthesized was investigated in in vitro gene transfection experiments
using several mammalian cell lines, including human pulmonary cells (A549 and
16HBE). The results allowed to unveil interesting structure-activity relationships
and to identify a formulation incorporating a small neamine derivative as a highly
efﬁcient gene delivery system.
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